Mode
Text Size
Log in / Sign up
N/A Completed N=28 Randomized Triple-blind Treatment

A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism

Source: ClinicalTrials.gov NCT01985308 ↗
Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcomePrimary: Childhood Autism Rating Scale 2nd Edition (CARS2) — -7.68; -1.61 units on a scale — p=0.0002

Summary

The purpose of this study is to show that a magnetic field applied to the front part of the brain of children suffering from Autism Spectrum Disorder(ASD) can improve function and ameliorate symptoms.

Outcome Measures

OutcomeResultp-value
PRIMARY
Childhood Autism Rating Scale 2nd Edition (CARS2)
-7.68; -1.61 0.0002 sig

Eligibility Criteria

Inclusion Criteria

  • Primary diagnosis of Autism Spectrum Disorder by Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) rendered by the examination and sufficient Childhood Autism Rating Scale 2nd Edition (CARS-2) score to qualify as autism.
  • CARS-2 score between 36 and 47 inclusively
  • Age between 4 and 12 years (at day of informed consent)
  • Child must suffer disrupted sleep patterns defined as a minimum of 3 nights per week of delayed onset of sleep or night-time awakenings. If these are medicated with mild sedatives or melatonin and corrected, the requirement for medication or melatonin will qualify as evidence of a sleep disorder.

Exclusion Criteria

  • Diagnosis of Asperger's Disorder, Pervasive Developmental Disorder Not Otherwise specified
  • History of clinically significant traumatic brain injury
  • Any condition associated with increased intracranial pressure
  • Cerebral Aneurysm
  • Down's Syndrome or other chromosomal abnormality
  • EEG abnormalities that indicate seizure risk
  • Intracranial implant
  • Unstable medical condition not otherwise specified
  • Clinically significant organic disease unrelated to autism
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01985308). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search